Playmates (00635) announced its performance for the year 2025 with a net loss of approximately HK$362 million for the company's owners, a decrease of 5.25% year-on-year.

18:21 13/03/2026

Rainbow Group (00635) announced its performance in 2025, with income of approximately HK$665 million, a decrease of 39.09% year-on-year; the company's attributable loss is approximately HK$362 million, a decrease of 5.25% year-on-year; loss per share is 17.51 HK cents, with a proposed second interim dividend of 1.5 HK cents per share and a special interim dividend of 1.5 HK cents per share.

PLAYMATES (00635) announced its performance for 2025, with revenue of approximately HK$665 million, a year-on-year decrease of 39.09%; the company's attributable loss is approximately HK$362 million, a year-on-year decrease of 5.25%; the loss per share is 17.51 HK cents. It is proposed to declare a second interim dividend of 1.5 HK cents per share and a special interim dividend of 1.5 HK cents per share.

Huiyu Pharmaceutical (688553.SH): Injection Carfizomib Obtained Drug Registration Certificate.

JINXUN RESOURCE (03636) announces expected comprehensive profit of approximately RMB 300 million to RMB 330 million for the year 2025.

7ROAD (00797) announces a profitable year with an estimated net profit attributable to shareholders of approximately 37 million yuan in the year 2025.

Huiyu Pharmaceutical (688553.SH): Injection Carfizomib Obtained Drug Registration Certificate.

JINXUN RESOURCE (03636) announces expected comprehensive profit of approximately RMB 300 million to RMB 330 million for the year 2025.

7ROAD (00797) announces a profitable year with an estimated net profit attributable to shareholders of approximately 37 million yuan in the year 2025.